News & Perspective

Jul 11, 2012

Jul 11, 2012

Study flags drop in antivirals for hospitalized flu patients

(CIDRAP News) – Researchers following recent antiviral trends in the United States have found a troubling drop in the use of the drugs for treating hospitalized patients with lab-confirmed flu, especially children.

Jun 20, 2012

Jun 20, 2012

ACIP reviews flu vaccine efficacy and safety, tweaks dosing for kids

(CIDRAP News) – The US Center for Disease Control and Prevention's (CDC) vaccine advisory group today heard the latest information on flu vaccine effectiveness and safety and updated its recommendation on the number of flu vaccine doses children under age 9 should receive.

May 14, 2012

May 14, 2012

Washington, other states face pertussis outbreak challenges

(CIDRAP News) – Washington state is battling its biggest pertussis outbreak in more than three decades, and cuts in local health department budgets are among the factors reported to be complicating the state's response to the epidemic.

Mar 01, 2012

Mar 01, 2012

FDA clears first quadrivalent flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the first quadrivalent influenza vaccine, an inhaled live attenuated influenza vaccine developed by MedImmune and modeled after its FluMist product.

The vaccine includes a second influenza B strain, which is designed to broaden protection against circulating strains. MedImmune plans to have the quadrivalent vaccine ready for the 2013-14 flu season.

Feb 27, 2012

Feb 27, 2012

Reports detail risk of seizures in kids after flu vaccination

(CIDRAP News) – A recent set of articles in Vaccine has confirmed previous preliminary reports that young children who received influenza shots in the 2010-11 flu season had a slightly increased risk of a febrile seizure after vaccination, especially if they received a new pneumococcal vaccine at the same time.

Feb 22, 2012

Feb 22, 2012

Vaccine advisors streamline pertussis advice for adults

(CIDRAP News) – Federal vaccine advisors today simplified their pertussis immunization recommendation for adults by advising that all those over age 19—including seniors 65 and older—should receive one dose of tetanus, diphtheria, and pertussis (Tdap) vaccine if they haven't received it already.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»